Bharat Biotech seeks DCGI nod for phase-II/III Covaxin booster trial
The study is likely to be conducted at six sites, including AIIMS Delhi and Patna
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.